Clinical Trials Logo

Clinical Trial Summary

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis.


Clinical Trial Description

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis. This study will include 50 patients with plasma cell mastitis. After providing written informed consent, the participants will receive traditional herbal medicine twice daily. Efficacy will be assessed every 15 days. If the disease progresses, the participant will withdraw from the trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05530226
Study type Interventional
Source Shengjing Hospital
Contact Nan Niu, MD
Phone +8618940256668
Email niunannancy@163.com
Status Recruiting
Phase Phase 2
Start date October 1, 2021
Completion date March 31, 2023